Ignite Creation Date:
2024-05-06 @ 10:20 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03222856
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2017-07-13
Brief Title:
Ph II Study of Pembrolizumab Eribulin in Patients With HRHER2- MBC Previously Treated With Anthracyclines Taxanes
Sponsor:
MedSIR
Organization:
MedSIR
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-23
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-13
First Submit QC Date:
July 17 2017
Study First Post Date:
2017-07-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-10
Last Update Post Date:
2022-06-13
Last Update Post Date Type:
ACTUAL